Objective 1:
Develop the I.D.E.F.I.X. project platform from proof-of-concept (TRL3/4) to a viable demonstrator (TRL6)
Objective 2:
Qualify the new platform with known drugs in a relevant environment with industrial and academic end-users using three different applications: type 2 diabetes, liver toxicity, and breast cancer.
Objective 3:
Make our MPS Disposable prototype into a product.